Two out of every 10 people have hypertension, one has diabetes, and the annual growth rate of cancer exceeds 10%!
How fortunate you should be that you are the healthy one!
China is widely recognized as a country with a high burden of chronic diseases. Chronic conditions such as hypertension are threatening public health, while the steady rise in healthcare expenditures has become a financial burden for individuals, the government, and enterprises, as well as a focal point of societal concern. The healthcare industry urgently needs new elements and transformative changes to deliver more effective, earlier, and cost-efficient health services and treatment modalities.
“Internet healthcare” is assuming this role, with the “Internet of Everything” and “data” becoming the core drivers of transformation in medicine. The field is evolving toward data-driven, dynamic, precise, and personalized care. In the course of developing Internet healthcare, we are collectively exploring the path forward:
What is the trend of domestic policies?
How Can Traditional Industries Such as Pharmaceuticals Transform to Embrace the Internet?
Can the business models for chronic disease management abroad be adopted in China?
VCBeat, in collaboration with the pharmaceutical research team at Galaxy Securities, has invited leading experts from government agencies, medical practitioners, traditional pharmaceutical companies undergoing transformation, and startups specializing in chronic disease management to engage in comprehensive discussions with investors.
The 7th VCBeat Salon – “Seminar on Investment in Chronic Disease and Health Management”
Time:July 23 (Thursday) 13:30–17:00
Location:Beijing Xicheng District (specific address will be notified via email after registration approval)
Salon Format: ThemeShare

Invited Experts and Topics: ○ Gu Xuefei, Deputy Director of the Medical Security System Research Office, Development Research Center of the National Health and Family Planning Commission
(Speech Topic: Medical Insurance, Health Management, and Internet Healthcare)
○ Xu Huansheng, General Manager of the O2O Business Division at Ciming Health Checkup
(Presentation Topic: Health Management in the Cloud Era)
○ Lin Hai, Founder of Kairui Nephrology Physician Group
(Speech Topic: Pragmatism and Innovation—On How Nephrologist Groups Can Launch Startups)
○ Chen Chen, Head of the Saint Medino Dynamic Blood Glucose Big Data Platform
(Topic: A Brief Discussion on “Internet + Smart Healthcare”)
○ Yin Lizheng, Head of the Mobile Healthcare Division, Wuxi Bohuis Biopharmaceutical Co., Ltd.
(Presentation Topic: The Development of Mobile Healthcare from the Perspective of Glycation Detection Devices)
○ Xu Feng, Co-founder of Tang Yisheng
(Presentation Topic: The Sweet Rebellion—Exploring Domestic and International Models for Entrepreneurship in Diabetes Chronic Disease Management)
- Here comes the key point!!!
Registration Method:only two steps 1. Follow the VCBeat WeChat Official Account
2. Send: Name + Email + Phone Number + Company + Job Title + Si Xiang Hui Salon to the VCBeat WeChat Official Account
Friendly Reminder: 1.
Registration Deadline: July 22, 18:00, limited spots available, act now!
2. After approval,
An email notification with the specific time and location will be sent on July 22 at 10:00 PM.!
Guest Details: Gu Xuefei, Deputy Director of the Medical Security System Research Office, Development Research Center of the National Health and Family Planning Commission Speech Topic: “Medical Insurance, Health Management, and Internet Healthcare”
Dr. Gu Xuefei has conducted in-depth research on the evolution of healthcare systems, comparative studies of national health insurance policies, internet-based healthcare, and health management, demonstrating a precise grasp of industry trends and policy developments.
Xu Huansheng, General Manager of the O2O Business Division at Ciming Health Checkup Presentation Title: 'Health Management in the Cloud Era'
Mr. Xu Huansheng is the founder of Beijing Health Cloud. With extensive product experience at top-tier internet companies, he possesses a profound understanding of the integration between traditional industries and the internet, and has successfully assisted numerous traditional enterprises in achieving strategic transformation.
Lin Hai, Founder of Kairui Nephrology Physician Group Presentation Title: “Pragmatism and Innovation: On How Nephrologist Physician Groups Can Launch Startups”
Kairui Physician Group is China’s first nephrology-focused physician group. Its partners are all renowned specialists in nephrology, hemodialysis, and vascular access within China, and the group plans to establish a chain of kidney disease treatment and hemodialysis centers. Founder Lin Hai was formerly an internist at Peking University Health Science Center, bringing extensive experience from multinational pharmaceutical companies and nine years of entrepreneurial expertise.
Chen Chen, Head of the Dynamic Blood Glucose Big Data Platform at Saint Medinno Speech Topic: "A Brief Discussion on 'Internet + Smart Healthcare'"
Shengmeidinuo is a Sino-US joint venture established in Zhejiang in 2003, an affiliate of Meida Shares, and the sole manufacturer of continuous glucose monitoring (CGM) devices in China, with its CGM systems deployed in over 1,000 hospitals nationwide. Mr. Chen Chen serves as the head of the company’s blood glucose big data platform.
Yin Lizheng, Head of the Mobile Healthcare Division, Wuxi Bohuis Biopharmaceutical Co., Ltd. Speech Topic: “The Development of Mobile Healthcare from the Perspective of Glycation Testing Devices”
A high-tech enterprise in Jiangsu Province, founded in 2006 by several renowned Chinese-American scientists, features a handheld glycated hemoglobin (HbA1c) analyzer as its flagship product. This device is the only commercially available A1c point-of-care testing (POCT) product globally and has been sold in more than 20 provinces across China and in multiple overseas countries. Private equity investment in the company has exceeded RMB 100 million. Li Zhengyin serves as the Head of the Medical Division; he previously worked at Good Doctor and has experience as a plastic surgeon at Peking Union Medical College Hospital.
Tang Yisheng Co-founder Xu Feng Presentation Title: “The Sweet Tooth’s Counterattack—Exploring Domestic and International Models for Entrepreneurship in Chronic Diabetes Management”
The Tang Yisheng app provides patients and physicians with features such as blood glucose logging, doctor–patient interaction, and diabetes education, positioning it among the top-tier companies in diabetes-focused entrepreneurial ventures. Xu Feng comes from an internet background, with prior experience including three years in banking, twelve years in vertical IT and internet media, and two years in online gaming.